General Information
Version
6.7
Revision date
2026-07-30
Product name
Ergotamine Tartrate, United States Pharmacopeia (USP) Reference Standard
CAS No.
379-79-3
Emergency telephone
+(31)-858880596
Icons in SDS
Company Information
company name
Merck Life Science N.V
e-mail address of the competent person responsible for the Safety Data Sheet
technischeservicebenelux@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H301+H311+H331, H311, H331, H361
Hazard statements
Code
Statements
H301
Toxic if swallowed
H301+H311+H331
Toxic if swallowed, in contact with skin or if inhaled
H311
Toxic in contact with skin
H331
Toxic if inhaled
H361
Suspected of damaging fertility or the unborn child
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H301 + H311 + H331 Toxic if swallowed, in contact with skin or if inhaled. H361 Suspected of damaging fertility or the unborn child.
Precautionary statements
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P301 + P330 + P331 + P310 IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. Immediately call a POISON CENTER/ doctor. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water. Call a POISON CENTER/ doctor if you feel unwell. P304 + P340 + P311 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor.
Storage
P403 + P233 Store in a well-ventilated place. Keep container tightly closed.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 3 H301: Toxic if swallowed. Acute toxicity, Category 3 H331: Toxic if inhaled. Acute toxicity, Category 3 H311: Toxic in contact with skin. Reproductive toxicity, Category 2 H361: Suspected of damaging fertility or the unborn child.
